Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedAug 14, 2026
DataAggregated Company Financials
Companies51
  • 7D1.0%
  • 3M3.9%
  • 1Y-5.9%
  • YTD9.6%

The Pharma industry is up 11% in the last week, with Curaleaf Holdings up 18%. In the past year, the industry is down 10%. In the next few years earnings are forecast to be pretty stable.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 14 Aug 2026CA$22.3bCA$13.5b-CA$872,907,937.849.2x-25.6x1.6x
Sun, 12 Jul 2026CA$13.7bCA$10.7b-CA$1,733,197,824.7410x-7.9x1.3x
Tue, 09 Jun 2026CA$18.0bCA$12.2b-CA$1,908,942,514.168.2x-9.4x1.5x
Thu, 07 May 2026CA$17.1bCA$11.2b-CA$1,493,416,887.4313.5x-11.4x1.5x
Sat, 04 Apr 2026CA$14.1bCA$11.4b-CA$1,659,446,578.4012.5x-8.5x1.2x
Mon, 02 Mar 2026CA$14.2bCA$11.2b-CA$1,765,189,451.0013.2x-8.1x1.3x
Wed, 28 Jan 2026CA$15.7bCA$11.1b-CA$1,927,393,253.8716.4x-8.1x1.4x
Fri, 26 Dec 2025CA$16.4bCA$11.2b-CA$1,935,422,909.6516.1x-8.5x1.5x
Sun, 23 Nov 2025CA$13.1bCA$11.4b-CA$1,931,233,676.1114.7x-6.8x1.1x
Tue, 21 Oct 2025CA$17.1bCA$11.3b-CA$2,043,116,736.0033.8x-8.4x1.5x
Thu, 18 Sep 2025CA$15.6bCA$11.2b-CA$2,027,187,216.2640.7x-7.7x1.4x
Sat, 16 Aug 2025CA$16.8bCA$11.8b-CA$2,552,698,606.6934.3x-6.6x1.4x
Mon, 14 Jul 2025CA$11.3bCA$11.7b-CA$2,540,996,725.9619.1x-4.5x1x
Wed, 11 Jun 2025CA$9.8bCA$11.7b-CA$2,516,681,135.6918x-3.9x0.8x
Fri, 09 May 2025CA$10.3bCA$12.0b-CA$2,507,839,408.9418.9x-4.1x0.9x
Sun, 06 Apr 2025CA$9.0bCA$12.3b-CA$2,621,301,298.1117.7x-3.4x0.7x
Tue, 04 Mar 2025CA$11.6bCA$12.3b-CA$2,419,205,511.6221.7x-4.8x0.9x
Thu, 30 Jan 2025CA$11.9bCA$12.2b-CA$2,413,956,152.1929.8x-4.9x1x
Sat, 28 Dec 2024CA$12.7bCA$12.2b-CA$2,416,843,548.7624.6x-5.3x1x
Mon, 25 Nov 2024CA$14.0bCA$11.8b-CA$2,558,921,605.2618.4x-5.5x1.2x
Wed, 23 Oct 2024CA$19.1bCA$11.8b-CA$2,710,231,074.9618.2x-7x1.6x
Fri, 20 Sep 2024CA$18.1bCA$11.6b-CA$2,694,675,910.4121x-6.7x1.6x
Sun, 18 Aug 2024CA$19.9bCA$11.7b-CA$2,742,747,277.7822x-7.3x1.7x
Tue, 16 Jul 2024CA$20.0bCA$11.7b-CA$3,183,280,462.5419.3x-6.3x1.7x
Thu, 13 Jun 2024CA$20.8bCA$11.8b-CA$2,770,274,645.8813.1x-7.5x1.8x
Sat, 11 May 2024CA$24.1bCA$11.9b-CA$3,375,957,081.8813.1x-7.2x2x
Mon, 08 Apr 2024CA$25.7bCA$11.9b-CA$3,481,114,387.218.7x-7.4x2.2x
Wed, 06 Mar 2024CA$21.1bCA$12.0b-CA$4,226,344,866.438.7x-5x1.8x
Fri, 02 Feb 2024CA$24.2bCA$12.3b-CA$6,712,858,880.008.8x-3.6x2x
Sun, 31 Dec 2023CA$17.9bCA$12.2b-CA$6,710,823,789.009.4x-2.7x1.5x
Tue, 28 Nov 2023CA$17.8bCA$12.4b-CA$6,818,754,003.006.9x-2.6x1.4x
Thu, 26 Oct 2023CA$16.1bCA$12.5b-CA$7,362,526,198.0011.4x-2.2x1.3x
Sat, 23 Sep 2023CA$20.3bCA$12.9b-CA$7,885,382,537.0014.3x-2.6x1.6x
Mon, 21 Aug 2023CA$14.0bCA$13.0b-CA$8,056,955,654.0013.1x-1.7x1.1x
Price to Earnings Ratio

-1.7x


Total Market Cap: CA$14.0bTotal Earnings: -CA$8,056,955,654.00Total Revenue: CA$13.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -6x202420252026
Current Industry PE
  • Investors are relatively neutral on the Canadian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 7.4% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market1.55%
Healthcare-0.66%
Pharma1.04%
Pharma1.04%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CURA Curaleaf HoldingsCA$13.504.4%
+CA$150.9m		11.7%PS2x
GTII Green Thumb IndustriesCA$10.287.1%
+CA$148.6m		-12.8%PE12.7x
ACB Aurora CannabisCA$5.2726.4%
+CA$71.3m		-29.1%PS1.1x
CRDL Cardiol TherapeuticsCA$2.4225.4%
+CA$56.5m		30.8%PB11.5x
OGI Organigram GlobalCA$1.7528.7%
+CA$54.9m		-18.2%PE2.8x

Latest News

RX
CA$15.01
BioSyent
7D
-3.1%
1Y
32.5%
APTX
CA$35.55
Apotex Health
7D
-5.2%
1Y
n/a
CPH
CA$13.99
Cipher Pharmaceuticals
7D
-21.2%
1Y
-2.8%
HLS
CA$3.87
HLS Therapeutics
7D
-3.3%
1Y
-24.0%
OGI
CA$1.75
Organigram Global
7D
28.7%
1Y
-18.2%
CURA
CA$13.50
Curaleaf Holdings
7D
4.4%
1Y
11.7%
ACB
CA$5.27
Aurora Cannabis
7D
26.4%
1Y
-29.1%
WEED
CA$1.41
Canopy Growth
7D
6.0%
1Y
-31.6%
Analysis Article • Aug 12

Earnings Release: Here's Why Analysts Cut Their Canopy Growth Corporation (TSE:WEED) Price Target To CA$2.02

It's been a good week for Canopy Growth Corporation ( TSE:WEED ) shareholders, because the company has just released...
VRNO
CA$8.37
Verano Holdings
7D
9.3%
1Y
-2.1%
VREO
CA$15.00
Vireo Growth
7D
6.8%
1Y
-49.5%
GUD
CA$9.21
Knight Therapeutics
7D
-3.1%
1Y
47.4%
GTII
CA$10.28
Green Thumb Industries
7D
7.1%
1Y
-12.8%
Analysis Article • Aug 07

The Green Thumb Industries Inc. (CSE:GTII) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Last week, you might have seen that Green Thumb Industries Inc. ( CSE:GTII ) released its second-quarter result to the...
NVRS
CA$0.29
Noveris Health Sciences
7D
-34.4%
1Y
-41.0%
SKNY
CA$0.17
LIR Life Sciences
7D
-36.5%
1Y
n/a
CRDL
CA$2.42
Cardiol Therapeutics
7D
25.4%
1Y
30.8%
Analysis Article • Jun 04

Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
PREV
CA$0.015
PreveCeutical Medical
7D
-25.0%
1Y
-50.0%